FDA Approves New Topical Antifungal Luliconazole 1%
FDA Approves New Topical Antifungal Luliconazole 1% Medscape
View ArticleValeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share...
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash Yahoo
View ArticleNot all pharmaceuticals are created equal
Not all pharmaceuticals are created equal Marketwatch
View ArticleJazz, Valeant Join Drug Makers' Q4 Merger Rush
Jazz, Valeant Join Drug Makers' Q4 Merger Rush Investors.com
View ArticlePfizer Is Old News, But Valeant Isn't
Pfizer Is Old News, But Valeant Isn't Seeking Alpha
View Article22 Biotech Stock Predictions for 2014
22 Biotech Stock Predictions for 2014 TheStreet.com
View ArticleValeant seeks to become top 5 pharmaceutical company -CEO
Valeant seeks to become top 5 pharmaceutical company -CEO Yahoo/Reuters
View ArticleValeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics Yahoo/Investors Business Daily
View ArticleValeant, Actavis, Mylan eye Pfizer's generics unit
Valeant, Actavis, Mylan eye Pfizer's generics unit Reuters
View ArticleValeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million
Valeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million Fierce Pharma
View ArticleActavis-Forest Bid Shines Light on Valeant Next: Real M&A
Actavis-Forest Bid Shines Light on Valeant Next: Real M&A Bloomberg
View ArticleValeant swings to profit on Bausch & Lomb buy
Valeant swings to profit on Bausch & Lomb buy Yahoo/Reuters
View ArticleDrugmakers Actavis, Biogen, Valeant Hold Near Highs
Drugmakers Actavis, Biogen, Valeant Hold Near Highs Investors.com
View ArticleValeant CEO Seeks Acquisitions in High-Growth Health Care
Valeant CEO Seeks Acquisitions in High-Growth Health Care Bloomberg
View ArticleValeant Targets Corporate ‘Fat’ in Push for Big Leagues
Valeant Targets Corporate ‘Fat’ in Push for Big Leagues Bloomberg
View ArticleNovartis to Shire Said to Weigh Bids for ThromboGenics
Novartis to Shire Said to Weigh Bids for ThromboGenics Bloomberg
View ArticleBillionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan
Billionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan Forbes
View ArticleWith Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug...
With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies Forbes
View Article